ALFASIGMA UK LIMITEDActive
Key figures
Ratios
2023Balance sheet structure
Filed accounts2020–2023
| 2020 | 2021 | 2023 | |
|---|---|---|---|
| Turnover | — | — | 20,469,913 |
| Profit for the year | — | — | 2,198,230 |
| Cash at bank and in hand | 468,874 | 834,264 | — |
| Total assets | 12,376,593 | 18,756,703 | 7,554,077 |
| Total liabilities | 5,428,998 | 8,409,087 | 2,805,677 |
| Net assets / total equity | 6,947,595 | 10,347,616 | 4,748,400 |
| Average number of employees | 22 | 62 | 56 |
| Average pay (per year) | — | — | 141,484 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2023The Company performs to a limited extent R&D activities and other support activities. During the year these activities were performed on behalf of the previous Belgian parent company of the Group, Galapagos NV. Therefore, the Company recharged its expenses incurred with a mark-up to Galapagos NV. In addition to the support and minor R&D activities, the Company sells the first medicine of the Galapagos group, Jyseleca, a product used to treat Rheumatoid Arthritis and Ulcerative Colitis.
As described in the company's latest filed accounts.
Summary: ALFASIGMA UK LIMITED
Company
ALFASIGMA UK LIMITED is a private limited company registered with Companies House under company number 03400161. It was incorporated on 8 Jul 1997. Its status is active. The registered office is in Cambridge (CB1). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files full accounts. Turnover was £20,469,913. Profit for the year was £2,198,230. Net assets were £4,748,400, down 54.1% on the previous year. Total assets were £7,554,077 and total liabilities £2,805,677. The company had an average of 56 employees. Figures are available for 3 financial years (2020–2023).
Control and charges
2 persons with significant control are registered. 2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 9 Apr 2027.